Sleptay
Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous system diseases.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredSep 27, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | 163.com |
Timeline
- Website created
Founders and team
- YGYang Geng Co-Founder & CEOsource: synphatec.com
- YCYelin Chen Founder & Chairmansource: synphatec.com
Investors
CChina Merchants Venture
DDecheng Capitallead investor
HHuatai Zijin Investment
MMorningside
- QQianju Capital
SShunwei Capital
Companies like Sleptay
CCreyon BioSeed · Mar 2022LLoxagen
SStarlight TherapeuticsSeed · Apr 2026
BBloom Science$12M Series A · Dec 2021
HHolobiomeSeed · Jul 2026
CClearideBio TherapeuticsPre Seed · Jun 2026
Other companies backed by Decheng Capital
PPhrontline Biopharma$40M Series A · Nov 2026
PPolares Medical$50M Series B+ · Mar 2026
YYolTech Therapeutics$45M Series B+ · Sep 2025
VVintaBio$64M · Apr 2023
MMirvie$60M Series B+ · May 2022
AAnHeart Therapeutics$61M Series B+ · Dec 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sleptay (get a free API key).